Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

The molecular and functional characterisation of dimethylarginine dimethylaminohydrolase in acute-on-chronic liver failure, and determination of its role in portal hypertension (360G-Wellcome-087688_Z_08_Z)

The pathobiology of portal hypertension in response to liver injury in acute-on-chronic liver failure (ACLF) is yet to be determined. Recent work has demonstrated an association of liver inflammation and abnormalities in the metabolism of asymmetric dimethylarginine (ADMA) with portal hypertension and prognosis in ACLF. We hypothesise that altered ADMA metabolism in response to liver inflammation may propagate liver injury and portal hypertension in ACLF. This project will explore th e effect of manipulation of ADMA metabolism in determining the response to liver injury in rodent models of cirrhosis. Genetic and pharmacological manipulation of dimethylarginine dimethylaminohydrolase (DDAH), the major enzymatic route of ADMA elimination, will be used to modulate the degree of liver injury in response to bacterial lipopolysaccharide administration. The key aims of the project are: 1. To characterise the effects of superadded inflammation on DDAH gene expression, protein expression, cellular localisation and activity, and on portal haemodynamics, in cirrhosis. 2. To determine the molecular effects and changes in hepatic haemodynamics following pharmacological interventions that modulate inflammation, oxidative stress and DDAH-1 expression, in cirrhosis. 3. To determine whether DDAH-1 over-expression confers protection against increased liver injury and mortality following superadded liver inflammation in cirrhosis.


01 Apr 2009

Grant details
Amount Awarded 185766
Applicant Surname Mehta
Approval Committee Clinical Interview Committee
Award Date 2009-04-01T00:00:00+00:00
Financial Year 2008/09
Grant Programme: Title Research Training Fellowship
Internal ID 087688/Z/08/Z
Lead Applicant Dr Gautam Mehta
Planned Dates: End Date 2012-09-01T00:00:00+00:00
Planned Dates: Start Date 2009-09-02T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London
Sponsor(s) Prof Rajiv Jalan
Additional data added by GrantNav